Chris Bangma

2.1k total citations
28 papers, 547 citations indexed

About

Chris Bangma is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Chris Bangma has authored 28 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Chris Bangma's work include Prostate Cancer Diagnosis and Treatment (22 papers), Prostate Cancer Treatment and Research (21 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Chris Bangma is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (22 papers), Prostate Cancer Treatment and Research (21 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Chris Bangma collaborates with scholars based in Netherlands, United States and Finland. Chris Bangma's co-authors include Ewout W. Steyerberg, Theodorus van der Kwast, Ulf‐Håkan Stenman, Hans Lilja, Wim J. Kirkels, E. P. Krenning, Fritz H. Schröder, Wytske M. van Weerden, Marion de Jong and Monique J. Roobol and has published in prestigious journals such as The Journal of Urology, International Journal of Cancer and European Urology.

In The Last Decade

Chris Bangma

27 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Bangma Netherlands	12	336	122	105	80	73	28	547
Takashi Fukagai Japan	14	477 1.4×	138 1.1×	187 1.8×	81 1.0×	100 1.4×	67	727
Lorenzo Tosco Belgium	14	629 1.9×	143 1.2×	109 1.0×	154 1.9×	73 1.0×	42	751
Rachel E. Carlson United States	15	610 1.8×	96 0.8×	141 1.3×	138 1.7×	59 0.8×	41	751
Stephen A. Brassell United States	18	598 1.8×	132 1.1×	147 1.4×	103 1.3×	52 0.7×	28	736
Kenneth R. Blank United States	10	669 2.0×	200 1.6×	174 1.7×	155 1.9×	90 1.2×	18	967
W A Sakr United States	7	605 1.8×	136 1.1×	102 1.0×	144 1.8×	65 0.9×	10	738
Masatoshi Muramoto Japan	8	419 1.2×	82 0.7×	80 0.8×	120 1.5×	59 0.8×	15	558
Lisa Moris Belgium	13	281 0.8×	104 0.9×	81 0.8×	77 1.0×	50 0.7×	36	450
Claartje Gosselaar Netherlands	12	578 1.7×	158 1.3×	160 1.5×	63 0.8×	58 0.8×	23	662
Sennett K. Kim United States	8	343 1.0×	66 0.5×	79 0.8×	70 0.9×	78 1.1×	13	499

Countries citing papers authored by Chris Bangma

Since Specialization

Citations

This map shows the geographic impact of Chris Bangma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Bangma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Bangma more than expected).

Fields of papers citing papers by Chris Bangma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Bangma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Bangma. The network helps show where Chris Bangma may publish in the future.

Co-authorship network of co-authors of Chris Bangma

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Bangma. A scholar is included among the top collaborators of Chris Bangma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Bangma. Chris Bangma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hemelrijck, Mieke Van, Xinge Ji, Jozien Helleman, et al.. (2021). A first step towards a global nomogram to predict disease progression for men on active surveillance. Translational Andrology and Urology. 10(3). 1102–1109. 1 indexed citations

Godtman, Rebecka Arnsrud, Sebastiaan Remmers, Gunnar Aus, et al.. (2021). Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer. European Urology Open Science. 34. 27–32. 2 indexed citations

Cremers, R.G.H.M., Marco H. Blanker, Christi J. van Asperen, et al.. (2021). Wanneer is onderzoek nodig bij prostaatkanker in de familie?. Huisarts en Wetenschap. 64(3). 69–71.

Brinkman, Willem M., Richard P. Meijer, Evert L. Koldewijn, et al.. (2020). Analysis of the video motion tracking system “Kinovea” to assess surgical movements during robot‐assisted radical prostatectomy. International Journal of Medical Robotics and Computer Assisted Surgery. 16(2). e2090–e2090. 11 indexed citations

Semjonow, Axel, Hans‐Werner Hense, Matthias Borowski, et al.. (2019). Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69 Yr: The PSAInForm Trial. European Urology. 76(1). 1–3. 3 indexed citations

Carlsson, Sigrid, Marianne Månsson, Sue Moss, et al.. (2019). Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?. European Urology. 75(6). 1015–1022. 13 indexed citations

Bangma, Chris & Henk Obbink. (2018). The future of prostate cancer research: bringing data together, looking back and forward. Translational Andrology and Urology. 7(1). 188–194. 1 indexed citations

Vasarainen, Hanna, Heidi Salminen, R. Valdagni, et al.. (2015). Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS). World Journal of Urology. 33(11). 1735–1740. 7 indexed citations

Carlsson, Sigrid, Alexandra C. Maschino, Fritz H. Schröder, et al.. (2013). Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam. European Urology. 64(5). 693–699. 67 indexed citations

10.

Schröder, Fritz H., Chris Bangma, J.C. Angulo, et al.. (2012). Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS). European Urology. 63(5). 779–787. 37 indexed citations

11.

Bergh, Roderick van den, Marie‐Louise Essink‐Bot, Tineke Wolters, et al.. (2010). Anxiety and distress during active surveillance for early prostate cancer. 18(1). 9–16. 12 indexed citations

12.

Valdagni, R., Peter Albers, Chris Bangma, et al.. (2010). The requirements of a specialist Prostate Cancer Unit: A discussion paper from the European School of Oncology. European Journal of Cancer. 47(1). 1–7. 26 indexed citations

13.

Aluwini, Shafak, Peter van Rooij, M.S. Hoogeman, et al.. (2010). CyberKnife Stereotactic Radiotherapy as Monotherapy for Low- to Intermediate-Stage Prostate Cancer: Early Experience, Feasibility, and Tolerance. Journal of Endourology. 24(5). 865–869. 38 indexed citations

14.

Weerden, Wytske M. van, et al.. (2009). Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. Methods. 48(2). 200–204. 67 indexed citations

15.

Stephan, Carsten, Chris Bangma, Giulio Vignati, et al.. (2009). 20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials – analysis of 1098 patients in four centers. The International Journal of Biological Markers. 24(2). 65–69. 24 indexed citations

16.

Aa, Madelon N.M. van der, Ellen C. Zwarthoff, Ewout W. Steyerberg, et al.. (2008). Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB]). European Urology. 55(3). 659–668. 71 indexed citations

17.

Theocharous, Panteli, Nicholas Russell, Stephen Todryk, et al.. (2007). A novel murine model of allogeneic vaccination against prostate cancer. Cancer Immunology Immunotherapy. 57(4). 453–465. 9 indexed citations

18.

Mongiat-Artus, P., Catherine Miquel, Olivier Buhard, et al.. (2006). Infrequent Microsatellite Instability in Urothelial Cell Carcinoma of the Bladder in Young Patients. European Urology. 49(4). 685–690. 17 indexed citations

19.

Finne, Patrik, Chris Bangma, Jonas Hugosson, et al.. (2004). Algorithms based on prostate‐specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false‐postitive PSA results in prostate cancer screening. International Journal of Cancer. 111(2). 310–315. 56 indexed citations

20.

Bangma, Chris. (2000). Screening for prostate cancer. Der Urologe. 39(4). 334–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact